356 reports of this reaction
1.8% of all POSACONAZOLE DELAYED RELEASE reports
#11 most reported adverse reaction
DIARRHOEA is the #11 most commonly reported adverse reaction for POSACONAZOLE DELAYED RELEASE, manufactured by A2A Integrated Pharmaceuticals. There are 356 FDA adverse event reports linking POSACONAZOLE DELAYED RELEASE to DIARRHOEA. This represents approximately 1.8% of all 20,089 adverse event reports for this drug.
Patients taking POSACONAZOLE DELAYED RELEASE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for POSACONAZOLE DELAYED RELEASE, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for POSACONAZOLE DELAYED RELEASE:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 356 FDA reports for POSACONAZOLE DELAYED RELEASE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 1.8% of all adverse event reports for POSACONAZOLE DELAYED RELEASE, making it a notable side effect.
If you experience diarrhoea while taking POSACONAZOLE DELAYED RELEASE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.